期刊文献+

难治性及复发性非霍奇金淋巴瘤放射治疗疗效的观察 被引量:2

下载PDF
导出
摘要 目的探讨三维适形放疗在大剂量化疗配合干细胞移植治疗难治性及复发性NHL的序贯治疗中的地位和作用。方法观察三维适形放疗对难治性及复发性NHL的疗效及副作用。结果26例难治性及复发性NHL患者中,在放疗结束后4周时,完全缓解(CR)9例(CR率34.6%),总有效率(CR+PR)为84.6%。能明显缓解局部疼痛及(或)局部压迫症状,B症状也明显缓解。结论三维适形放疗对难治性及复发性NHL有较好的完全缓解率及总有效率,且副作用少,经济易实施,配合挽救性化疗,能提高移植前缓解率。三维适形放疗在大剂量化疗配合干细胞移植治疗难治性及复发性NHL的序贯治疗中的地位和作用应得到进一步重视及深入研究。
出处 《广州医药》 2007年第1期31-33,共3页 Guangzhou Medical Journal
  • 相关文献

参考文献8

二级参考文献22

  • 1[1]Jaffe ES,Harris NL,Stein H,et al.World Health Organization Classification of tumors.Pathology and genetics of tumours of haematopoietic and lymphoid tissues.Lyon,France:IARC Press,2001
  • 2[2]DeVita VT Jr,Canellos GP,Chabner B,et al.Advanced diffuse histiocytic lymphoma:A potentially curable disease,Lancet,1975,1:248
  • 3[3]Fisher RI,Gaynor ER,Dahlberg S,et al.Comparison of a standar regimem (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.N Engl J Med,1993,328:1002
  • 4[4]Linch DC,Vaughan Hudson B,Hancock BW,et al.A randomized comparison of a third-generation regimen (PACEBOM)with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma:A British National Lymphoma Investigation report.Br J Cancer,1996,74:318
  • 5[5]Pfreundschuh M,Truemper L,Kloess M,et al.2-weekly vs 3-weekly CHOP with and without etoposide for patients > 60 years of age with aggressive non-Hodgkin's lymphoma (NHL):Results of the completed NHL-B-2 trial of the DSHNHL.Blood,2004,104:634
  • 6[6]Tilly H,Lepage E,Coiffer B,et al.Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin's lymphoma.Blood,2003,102:4284
  • 7[8]Coiffier B,Haioun C,Ketterer N,et al.Rituximab (antiCD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma:A multicenter phase Ⅱ study.Blood,1998,92:1927
  • 8[9]Vose JM,Link BK,Grossbard ML,et al.Phase Ⅱ study of rituximab in combination with CHOP chemotherapy in patients with previously untreated,aggressive non-Hodgkin's lymphoma.J Clin Oncol,2001,19:389
  • 9[10]Vose JM,Link BK,Grossbard ML,et al.Long term follow-up of a phase Ⅱ study of rituximab in combination with CHOP chemotherapy in patients with previously untreated aggressive non-Hodgkin's lymphoma (NHL).Blood,2002,100:36A
  • 10[11]Sehn LH,Jane Donaldson J,Chhanabhai M,et al.Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.J Clin Oncol,2005,23:5027

共引文献37

同被引文献18

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部